AIDS Healthcare Foundation (AHF) says Moderna’s promise to build a state-of-the-art mRNA manufacturing facility in Africa in 2022 was nothing more than a self-serving effort to deflect criticism for price gouging …
AHF Backs Africa CDC Push to Curb Cholera
In light of the ongoing acute cholera crisis and vaccine shortages across parts of Eastern and Southern Africa, AIDS Healthcare Foundation (AHF) strongly supports efforts by the Africa Centres for Disease Control and Prevention …
AHF Urges President Biden to Support WTO IP Waiver
AIDS Healthcare Foundation (AHF) calls on President Biden to support a proposal for an expanded waiver on intellectual property (IP) rights for COVID-19 treatments and diagnostics currently being advanced at …
Anthrax Outbreak Exposes Global Health Inequities
With outbreaks of anthrax and another potentially unidentified disease having caused nearly 1,200 suspected cases and 20 deaths across five African countries, AIDS Healthcare Foundation (AHF) urges wealthy countries to …
AHF Echoes WTO’s Call for Patent Flexibilities
AIDS Healthcare Foundation (AHF) praised today the head of the World Trade Organization, Dr. Ngozi Okonjo Iweala, for calling on developing countries to put in place legal mechanisms to suspend …
AHF Urges Affordable Access to New Dengue Drug
The AIDS Healthcare Foundation (AHF) commends Johnson & Johnson (J&J) for developing a pill that has shown promising results in a small trial for protecting against dengue fever and urges …
Patients Suffer as Pfizer Pockets Profits
The AIDS Healthcare Foundation (AHF) rebuked pharmaceutical giant Pfizer today for announcing that it plans to charge $1,400 for a five-day course of the COVID-19 antiviral drug Paxlovid. During the pandemic, the U.S. government …
Newly Approved Malaria Vaccine Is a Win for Global Health
AIDS Healthcare Foundation (AHF) applauds the World Health Organization’s (WHO) recommendation of a new malaria vaccine, R21/Matrix-M, for preventing malaria, which disproportionately affects African children. The affordable and easily deployable vaccine is a …
AHF Slams J&J’s Vaccine Hostage Tactics in South Africa
According to a Health Policy Watch story, Johnson & Johnson (J&J) used scarcity during the COVID-19 pandemic as leverage to charge South Africa inflated prices on vaccine doses – a tactic …
J&J-Stop TB Partnership Deal a Positive Step but More Is Needed
With Johnson and Johnson (J&J) recently granting permission to Stop TB Partnership to distribute its generic TB drug bedaquiline (SIRTURO) to the majority of low- and middle-income countries, AIDS Healthcare …
